Department of Dermatology

Publications:

View Dr. Korman's publications in PubMed

View Dr. Korman's PubMed by Topic:
Autoimmune Blistering Diseases, Immunodermatology, Psoriasis, Atopic Dermatitis.

Publicaionts Prior to 2002

  1. Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, Korman NJ: Significant absorption of topical tacrolimus in three patients with Netherton Syndrome. Arch Dermatol 137:747-750, 2001.
  2. Drake L, Prendergast M, Maher RM, Breneman D, Korman NJ, Satoi Y: The impact of tacrolimus ointment on health-related quality-of-life in adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 44:S65-72, 2001.
  3. Fleming TE, Korman NJ: Cicatricial Pemphigoid. J Am Acad Dermatol 43:571-591, 2000.
  4. Walmsley S, Northfelt DW, Melosky B, Conant M, Friedman-Kien AE, Wagner B and 28 collaborating investigators (Korman NJ): Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. J Acquir Immune Defic Syn 22:235-46, 1999.
  5. Korman NJ: Bullous pemphigoid. The latest in diagnosis, prognosis and therapy..Arch Dermatol 134:1137-1141, 1998.
  6. Chopra A, Maitra B, Korman NJ: Decreased mRNA expression of several basement membrane components in basal cell carcinoma. J Invest Dermatol 110:52-56, 1998.
  7. Bonomo RA, Korman NJ, Nagashima-Whalen L, Briggs J, Graham R, Salata R: Pityriasis rubra pilaris: An unusual complication of the acquired immunodeficiency syndrome (AIDS). Am J Med Sci 314:118-121, 1997.
  8. Katiyar SK, Korman NJ, Mukhtar H, Agarwal R: Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst 89:556-566, 1997.
  9. Korman NJ, Watson RD: Immune-mediated subepithelial blistering diseases of the mucous membranes: Improving the detection of circulating autoantibodies by the use of concentrated sera. Arch Dermatol 132:1194-1198, 1996.
  10. Izaki S, Yoshizawa Y, Hashimoto T, Korman NJ, Kitamura K, Hamamatsu N, Ohashi N, Ogasa S: Paraneoplasic pemphigus: report of a case. J Dermatol 23: 397-404, 1996.
  11. Brodell RT, Korman NJ: Stump Pemphigoid. Cutis 57:245-6, 1996.
  12. Agarwal R, Korman NJ, Mohan RR, Jawed S, Zaim MT, Mukhtar H: Apoptosis is an early event during phthalocyanine-photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin. Photochem Photobiol 64:547-552, 1996.
  13. Izaki S, Yoshizawa Y, Hashimoto T, Korman NJ, Kitamura K, Hamamatsu N, Ohashi N, Ogasa S: Paraneoplasic pemphigus: potential therapeutic effect of plasmapheresis. Br J Dermatol 134: 987-989, 1996.
  14. Korman NJ, Woods S: Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid. Br J Dermatol 133:967-971, 1995.
  15. Korman NJ: In Situ Bound Antibodies Eluted From the Skin of Patients with Bullous Pemphigoid Are Preferentially Directed Against the 230 KD Bullous Pemphigoid Antigen: J Invest Dermatol 105:824-30, 1995.
  16. Katiyar SK, Rupp CO, Korman NJ, Agarwal R, Mukhtar H: Inhibition of tumor promoter-caused induction of interleukin 1-alpha gene expression in SENCAR mouse skin by tea polyphenols. J Invest Dermatol 105:394-398, 1995.
  17. Ostezan LB, Fabre V, Caughman SW, Korman NJ, Callen JP: Paraneoplastic pemphigus in the absence of a known neoplasm. J Am Acad Dermatol 33:312-315, 1995.
  18. Nishibori Y, Hashimoto T, Ishiko A, Shimizu H, Korman NJ, Nishikawa T: Paraneoplastic pemphigus: the first report form Japan. Dermatology 191:39-42, 1995.
  19. Hashimoto T, Amagai M, Korman NJ, Nishikawa T: Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 104:829-834, 1995.
  20. Chorzelski TP, Hashimoto T, Korman NJ, Jabonskla S, Kozlowska A, Ismail M, Rywik H: Atypical pemphigus associated with malignant thymoma and autoimmune response restricted to 170 KD antigen: is it a variant of paraneoplastic pemphigus? Eur J Derm 5:31-5, 1995.
  21. Wisnieski JJ, Emancipator SM, Korman NJ, Lass JH, Zaim MT, McFadden ER: Hypocomplementemic urticartial vasculitis syndrome. Arth Rheum 37:1105-1111, 1994.
  22. Ibanez HE, Bardenstein DS, Korman NJ, Reinhart WJ: Exuberant conjunctival pseudopolyposis in a patient with dermatomyositis. Ann Ophth 25:326-327, 1993.
  23. Chorzelski TP, Stefanato CM, Stanley JR, Beutner E, Korman NJ, Olszewska M, Maciejowska E, Jabonskla S: Erythema annulare-like acantholytic dermatosis: Non-bullous pemphigus or a new entity? Am J Med Sci 306:145-150, 1993.
  24. Korman NJ, Hrabovsky SL: Basal cell carcinomas display extensive abnormalities in he hemidesmosome anchoring fibril complex. Exp Dermatol 2:139-144, 1993.
  25. Camisa C, Helm TN, Liu YC, Valenzuala R, Alen C, Bona S, Larrimer N, Korman NJ: Paraneoplastic pemphigus: A report of three cases including one long term survivor. J Am Acad Dermatol 27:547-552, 1992.
  26. Korman NJ, Stanley JR, Woodley DT: Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. Arch Dermatol 127:387-390, 1991.
  27. Korman NJ, Eyre RW, Zone J, Stanley JR: Drug-induced pemphigus: Autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 96:273-276, 1991.
  28. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H III, Mutasim D, Ariss-Abdo L, and Labib RS: A novel autoimmune mucocutaneous syndrome, associated with underlying neoplasia: "Paraneoplastic Pemphigus". N Engl J Med 323:1729-1735, 1990.
  29. Rico MJ, Korman NJ, Stanley JR, Tanaka T, Hall RP: IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA. J Immunol, 145:3728-3733, 1990.
  30. Greenberg SJ, Jaffe ES, Ehrlich GD, Korman NJ, Poiesz BJ, Waldmann TA: Kaposi`s sarcoma in human T-cell leukemia virus type I-associated adult T-cell leukemia. Blood 76:971-976, 1990.
  31. Robledo MA, Kim SC, Korman NJ, Stanley JR, Labib RS, Futamura S, Anhalt GJ: Studies of the relationship of the 230-Kd and 180-Kd bullous pemphigoid antigens. J Invest Dermatol 94:793-797, 1990.
  32. Tanaka T, Korman NJ, Shimzu H, Eady RAS, Klaus-Kovtun V, Cehrs K, and Stanley JR: Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol 94:617-623, 1990.
  33. Korman NJ, Eyre RW, Klaus-Kovtun V, and Stanley JR: Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N Engl J Med 321:631-635, 1989.
  34. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE: Topical capsaicin treatment of chronic post-herpetic neuralgia. J Am Acad Dermatol 21:265-270, 1989.
  35. Korman NJ: Pemphigus. J Am Acad Dermatol 18:1219-1238, 1988.
  36. Korman NJ: Bullous pemphigoid. J Am Acad Dermatol 16:907-924, 1987.
  37. Korman NJ, Sudilovsky O, Gibbons DF: The effect of humoral components on the cellular response to textured and non-textured polytetrafluoroethylene. J Bio Mater Res 18:225-241, 1984.
  38. Korman NJ, Sudilovsky O, Gibbons DF: A model for the production of large volume exudates from the implant-tissue interface. J Bio Mater Res 16:87-91, 1982.

Invited, Non-Peer Reviewed

  1. Korman NJ: Pemphigus: An update. Prog Dermatol 24:1-6, 1990.
  2. Korman NJ. Pemphigus: Dermatol Clin 8:689-700, 1990.
  3. Korman NJ: Bullous pemphigoid. Dermatol Clin 11:483-498, 1993.
  4. Korman NJ: Paraneoplastic pemphigus: a distinctive autoimmune syndrome. Med & Surg Derm 2:3-6, 1995.
  5. Korman, NJ: Pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus. J Geriatric Derm 4:53-62, 1996.
  6. Korman, NJ: Update on the use of azathioprine in the management of pemphigus and bullous pemphigoid. Med & Surg Derm 3:209-213, 1996.
  7. Korman, NJ: Update on the use of cyclophosphamide in the management of pemphigus, bullous pemphigoid and cicatricial pemphigoid. Med & Surg Derm 5:1-6, 1998.
  8. Korman, NJ: New and emerging therapies in the treatment of blistering diseases. Dermatol Clin 18:127-137, 2000.
  9. Korman NJ: New immunomodulating drugs in autoimmune blistering diseases. Dermatol Clin 19: 637-648, 2001.
  10. Korman, NJ, Moul, DK: Alefacept for the Treatment of Psoriasis: A Review of the Current Literature and Practical Suggestions for Everyday Clinical Use. Sem Cut Med Surg 24:10-18, 2005
  11. Patton T, Korman NJ. Bullous pemphigoid treatment review. Expert Opin Pharmacother. 7:2403-2411; 2006
  12. Patton T, Korman NJ: The Role of Methotrexate for the Treatment of Bullous Pemphigoid in the Elderly. Drugs Aging. 2008; 25:623-9.
  13. Sugiyama H, McCormick TS, Cooper KD, Korman NJ: Alefacept in the Treatment of Psoriasis. Clin Dermatol. 2008; 26:503-8.
  14. Bahner J, Cao L, Korman NJ: Biologics in the management of psoriasis. Clinical Cosmetic and Investigative Dermatology 2009 2:111-128.
  15. Korman NJ. Comorbid disease in psoriasis. In: UpToDate, Basow DS (Ed), UpToDate, Waltham, MA, 2011
  16. Kittridge A, Al-Dabagh A, Korman NJ. Diagnosis and Treatment of Pemphigus Vulgaris, In “Treatment Strategies - Dermatology”, 2:37-43, 2012.
  17. Churton S, Doud K, Korman NJ: Co-morbidities of Psoriasis. Exp Rev Dermatol, 8:277-290, 2013.
  18. Churton S, Brown L, Shin S, Korman NJ: Systemic Treatment of Psoriasis May Reduce the Risk of Heart Disease. Drugs, 74: 169-82, 2014
  19. Korman, NJ: Linear IgA Bullous Dermatosis and Chronic Bullous Dermatosis of Childhood. In Press, 2014.
  20. Grozdev I, Korman NJ, Tsankov N. Psoriasis as a systemic disease Clin Dermatol 32, 343-350, 2014.

Book Chapters

  1. Korman NJ: Bullous pemphigoid in Bullous Diseases. J.D. Fine (ed), Igaku-Shoin, New York, N.Y, 1992, pp 25-51.
  2. Korman NJ: Laboratory methods in the diagnosis of autoimmune blistering diseases. in Current Opinion in Dermatology. MV Dahl, PJ Lynch (ed), Current Science, Philadelphia, 1994, pg 16-20.
  3. Korman NJ: Bullous pemphigoid. In Cutaneous Medicine and Surgery: An Integrated Program in Dermatology. Arndt KA, LeBoit PE, Robinson JK, and Wintroub BU, Editors. W.B. Saunders Co., Philadelphia, PA, 1995, pg 664-673.
  4. Korman, NJ: Skin diseases of pregnancy. In Conn’s Current Therapy. Rakel RE, Editor. W.B. Saunders Co., Philadelphia PA, 1996, pg 813-815
  5. Korman, NJ, Goldstein SM, Wintroub BU: Immune mediated dermatologic diseases. In Basic and Clinical Immunology. Stites R, Terr AI, Editors. Appleton & Lange, Philiadelphia, PA, 1997, pg 564-578.
  6. Korman, NJ: Bullous pemphigoid and other immunologically mediated blistering diseases. In Dermatology: Cutaneous Medicine and Surgery in Primary Care. Arndt KA, LeBoit PE, Robinson JK, and Wintroub BU, Editors. WB Saunders Co., Philadelphia, PA, 1997, pg 233- 241.
  7. Korman, NJ: Bullous diseases. In Conn’s Current Therapy. Rakel RE, Editor. W.B. Saunders Co., Philadelphia PA, 2000, pg 826-830, 2000.
  8. Korman, NJ, Cooper KD: Cicatricial pemphigoid. In Atlas of Bullous Disease R.E. Jordon, Editor. Churchill Livingstone, New York, NY, 2000, pg 63-74.
  9. Korman, NJ: Skin diseases of pregnancy. In Conn’s Current Therapy. Rakel RE, Editor. W.B. Saunders Co., Philadelphia, PA, 2001, pg 881-883.
  10. Korman, NJ: Immune mediated dermatologic diseases. In Medical Immunology, Parslow TG, Stites DP, Terr AI, Imboden JB, Editors McGraw-Hill, New York, 2001 pg 495-509.
  11. Korman, NJ: Linear IgA bullous dermatosis and chronic bullous dermatosis of childhood. In Treatment of Skin Disease: Comprehensive Therapeutic Strategies, Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, Editors, Mosby, London, 2002, pg 361-364.
  12. Korman, NJ: Macular, papular, vesiculobullous and pustular diseases. In Cecil Textbook of Medicine, Goldman L, Ausiello D, Editors, W.B. Saunders Co., Philadelphia, PA, 2004, pg 2466-2475.
  13. Korman, NJ: Linear IgA bullous dermatosis and chronic bullous dermatosis of childhood. In Treatment of Skin Disease: Comprehensive Therapeutic Strategies, Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, Editors, Mosby, London, 2006.
  14. Routhouska SB, Cooper KD, Korman NJ: Anti-Interleukin-12/23. In Asadullah K, Volk HD and Sterry W, Editors: Cytokine and Anti-Cytokine Therapy in Dermatology. Kerala, India, 2006, Transworld Research Network. Chapter 14, pages 212-41.
  15. Korman, NJ: Macular, Papular, Vesiculobullous and Pustular Diseases. In Cecil Textbook of Medicine, Goldman L, Ausiello D, Editors, W.B. Saunders Co., Philadelphia, PA, 2007. pg 2946-2957.
  16. Brown AB, Korman NJ: Psoriasis and Psoriatic Arthritis: A Clinical Review. In Weinberg JM, Editor, Treatment of Psoriasis, Birkhauser, Boston, MA, 2008. pg 23-39.
  17. Prodanovich E, Korman NJ: Treatment of Psoriasis With Traditional Systemic Therapies. In Weinberg JM, Editor, Treatment of Psoriasis, Birkhauser, Boston, MA, 2008. pg 103-120.
  18. Robinson MR, Korman NJ: Treatment of Psoriasis Utilizing Biologic and Oral Therapies in Development. In Weinberg JM, Editor, Treatment of Psoriasis, Birkhauser, Boston, MA, 2008. pg 159-164.
  19. Korman, NJ: Linear IgA bullous dermatosis and chronic bullous dermatosis of childhood. In Treatment of Skin Disease: Comprehensive Therapeutic Strategies, Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, Editors, Mosby, London, 2009.
  20. Patton T, Korman NJ: Autoimmune Blistering Diseases of the Skin and Mucous Membranes. In Challenging Cases in Allergic and Immunologic Diseases of the Skin. Mahmoudi M, Editor, Springer, New York, 2010, Pg 303-321.
  21. Kwasniak LA, Korman NJ. Diagnosis and Treatment Of Bullous Pemphigoid. In “Treatment Strategies – Dermatology” 1:146-149, 2011.
  22. Grozdev I, Korman NJ, Tsankov N. Psoriasis as a systemic disease Clin Dermatol 32, 343-350, 2014.